Michael M. Ward

28.9k total citations · 3 hit papers
290 papers, 14.2k citations indexed

About

Michael M. Ward is a scholar working on Rheumatology, Immunology and Surgery. According to data from OpenAlex, Michael M. Ward has authored 290 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Rheumatology, 60 papers in Immunology and 31 papers in Surgery. Recurrent topics in Michael M. Ward's work include Rheumatoid Arthritis Research and Therapies (111 papers), Systemic Lupus Erythematosus Research (99 papers) and Spondyloarthritis Studies and Treatments (98 papers). Michael M. Ward is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (111 papers), Systemic Lupus Erythematosus Research (99 papers) and Spondyloarthritis Studies and Treatments (98 papers). Michael M. Ward collaborates with scholars based in United States, United Kingdom and Australia. Michael M. Ward's co-authors include Abhijit Dasgupta, Isam Atroshi, Christina Gummesson, Maria G. Tektonidou, Stephanie Studenski, Massimo Gadina, Alejandro V. Villarino, Yuka Kanno, John J. O’Shea and Daniella M. Schwartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Michael M. Ward

278 papers receiving 13.7k citations

Hit Papers

JAK inhibition as a thera... 2006 2026 2012 2019 2017 2006 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
    2017 909 citations Michael M. Ward et al. profile →
  2. The shortened disabilities of the arm, shoulder and hand questionnaire (Quick DASH): validity and reliability based on responses within the full-length DASH
    2006 832 citations Michael M. Ward et al. profile →
  3. Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐Analysis
    2016 365 citations Maria G. Tektonidou, Abhijit Dasgupta et al. Arthritis & Rheumatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael M. Ward 8.5k 4.1k 2.0k 1.9k 1.5k 290 14.2k
Loreto Carmona 7.3k 0.9× 2.6k 0.6× 2.5k 1.3× 2.5k 1.3× 1.4k 0.9× 370 14.0k
Paul R. Fortin 7.3k 0.9× 3.5k 0.9× 1.2k 0.6× 2.1k 1.1× 1.5k 1.0× 217 11.9k
John M. Esdaile 6.6k 0.8× 2.1k 0.5× 1.7k 0.9× 2.1k 1.1× 1.7k 1.2× 272 13.6k
Annelies Boonen 9.1k 1.1× 3.2k 0.8× 2.9k 1.4× 1.5k 0.8× 950 0.6× 427 13.7k
Graciela S. Alarcón 8.8k 1.0× 3.9k 0.9× 1.5k 0.7× 729 0.4× 1.8k 1.2× 320 12.5k
Ann E. Clarke 5.6k 0.7× 3.2k 0.8× 962 0.5× 1.5k 0.8× 1.6k 1.1× 304 11.2k
Frederick Wolfe 9.3k 1.1× 1.8k 0.4× 3.0k 1.5× 1.9k 1.0× 1.3k 0.9× 39 13.6k
Frederick Wolfe 10.6k 1.2× 2.2k 0.5× 3.0k 1.5× 2.0k 1.1× 2.0k 1.3× 205 24.4k
Kaleb Michaud 8.5k 1.0× 2.0k 0.5× 3.0k 1.5× 1.1k 0.6× 1.8k 1.2× 266 13.7k
Javier Llorca 6.0k 0.7× 2.6k 0.6× 758 0.4× 1.9k 1.0× 1.1k 0.8× 479 15.7k

Countries citing papers authored by Michael M. Ward

Since Specialization
Citations

This map shows the geographic impact of Michael M. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Ward more than expected).

Fields of papers citing papers by Michael M. Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Ward. The network helps show where Michael M. Ward may publish in the future.

Co-authorship network of co-authors of Michael M. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Ward. A scholar is included among the top collaborators of Michael M. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Ward. Michael M. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gensler, Lianne S., Michael M. Ward, Mark C. Hwang, et al.. (2025). Associations of sociodemographic, clinical factors and HLA-B alleles with enthesitis and peripheral arthritis in patients with ankylosing spondylitis. RMD Open. 11(1). e004589–e004589. 1 indexed citations
2.
3.
Tektonidou, Maria G., Ricard Cervera, Anǵela Tincani, et al.. (2025). Methodology of the development of the EULAR Antiphosholipid Syndrome Disease Activity Score (EAPSDAS).
4.
Ward, Michael M.. (2024). Smoking-related bias of standardized mortality ratios in rheumatoid arthritis: A modeling study. Seminars in Arthritis and Rheumatism. 70. 152599–152599. 1 indexed citations
5.
Hwang, Mark C., John D. Reveille, Lianne S. Gensler, et al.. (2022). Why Do Some Patients Have Severe Sacroiliac Disease But No Syndesmophytes in Ankylosing Spondylitis? Data From a Nested Case-Control Study. The Journal of Rheumatology. 50(3). jrheum.211230–jrheum.211230. 1 indexed citations
6.
Hwang, Mark C., MinJae Lee, Lianne S. Gensler, et al.. (2021). Repeated Spinal Mobility Measures and Their Association With Radiographic Damage in Ankylosing Spondylitis. ACR Open Rheumatology. 3(6). 413–421.
7.
Ward, Michael M.. (2021). Trends in Permanent Work Disability Associated With Rheumatoid Arthritis in the United States, 1999–2015. Arthritis Care & Research. 74(8). 1321–1324. 3 indexed citations
8.
Hwang, Mark C., MinJae Lee, Lianne S. Gensler, et al.. (2020). Longitudinal associations between depressive symptoms and clinical factors in ankylosing spondylitis patients: analysis from an observational cohort. Rheumatology International. 40(7). 1053–1061. 9 indexed citations
9.
Liew, Jean W., Michael M. Ward, John D. Reveille, et al.. (2019). Nonsteroidal Antiinflammatory Drug Use and Association With Incident Hypertension in Ankylosing Spondylitis. Arthritis Care & Research. 72(11). 1645–1652. 26 indexed citations
10.
Tektonidou, Maria G., Abhijit Dasgupta, & Michael M. Ward. (2016). Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐Analysis. Arthritis & Rheumatology. 68(6). 1432–1441. 365 indexed citations breakdown →
11.
Ward, Michael M., Michael H. Weisman, Matthew A. Brown, et al.. (2015). Gender differences in ankylosing spondylitis: Men derive greater benefit from tumor necrosis factor alpha inhibitors. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
12.
Gibson, Mary, MinJae Lee, Michael M. Ward, et al.. (2015). Factors associated with anti-TNF treatment in a longitudinally followed ankylosing spondylitis (AS) cohort. Queensland's institutional digital repository (The University of Queensland).
13.
Wang, Runsheng, Abhijit Dasgupta, & Michael M. Ward. (2015). Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials. Annals of the Rheumatic Diseases. 75(6). 1152–1160. 43 indexed citations
14.
Patterson, Sarah L., John D. Reveille, MinJae Lee, et al.. (2014). Better outcomes in ankylosing spondylitis: the synergistic association between exercise and tumor necrosis factor inhibitors. Queensland's institutional digital repository (The University of Queensland). 66. 2 indexed citations
15.
Zhou, Xiaodong, Michael H. Weisman, Michael M. Ward, et al.. (2014). Shared HLA Class I and II Alleles in Susceptibility to Ankylosing Spondylitis Among Three Ethnic Groups.. Queensland's institutional digital repository (The University of Queensland). 66. 1 indexed citations
16.
Gensler, Lianne S., Michael M. Ward, MinJae Lee, et al.. (2013). Cardiovascular Disease Is Associated With Worse Functional Outcomes In Ankylosing Spondylitis. Queensland's institutional digital repository (The University of Queensland). 2 indexed citations
17.
18.
Reveille, John D., Walter P. Maksymowych, Michael M. Ward, et al.. (2008). Genomewide association study in Ankylosing spondylitis identifies major Non-MHC genetic determinants of disease susceptibility. Clinical and Experimental Rheumatology. 26. 723–723. 2 indexed citations
19.
Ward, Michael M., A Ferguson, & M. A. Eastwood. (1979). Jejunal lysozyme activity and the Paneth cell in coeliac disease.. Gut. 20(1). 55–58. 13 indexed citations
20.
Ward, Michael M.. (1976). Crohn's disease of colon presenting as irritable bowel syndrome.. BMJ. 1(6012). 748.2–749. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Loreto Carmona Breakdown of academic impact, for papers by Paul R. Fortin Breakdown of academic impact, for papers by John M. Esdaile Breakdown of academic impact, for papers by Annelies Boonen Breakdown of academic impact, for papers by Graciela S. Alarcón Breakdown of academic impact, for papers by Ann E. Clarke Breakdown of academic impact, for papers by Frederick Wolfe Breakdown of academic impact, for papers by Frederick Wolfe Breakdown of academic impact, for papers by Kaleb Michaud Breakdown of academic impact, for papers by Javier Llorca
Rankless by CCL
2026